Principles of Y-90 Dosimetry and Tumor Coverage

Forgot your password?

Select specialty

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

By SYNERGY FEATURING David Liu

March 25, 2015

Malkhaz Mizandari

SIR 2024 Insights

Penn Medicine Abramson Cancer Center

SIR 2022 Coverage

Shamar Young

Boston Scientific

Boston Scientific

Memorial Sloan Kettering Cancer Center

Cedars Sinai

J. Marrero, W. C. Maddrey

Boston Scientific

Siddharth Padia

Theresa Caridi

Ripal Gandhi

Ripal Gandhi

Symposium on Clinical Interventional Oncology (CIO 2018)

Nicholas Fidelman

TREAT Symposium

Login

Login

Join VuMedi

Principles of Y-90 Dosimetry and Tumor Coverage

Related Content

Y90 Radioembolization for Locally Advanced HCC

HCC Percutaneous Radio-Ablation Using BAT-90: Results of an Ongoing …

SIR 2024 Insights: Route90 US IDE Pivotal Study Early Results in Rad…

Colorectal Liver Metastases: Liver-Directed Therapies - Embolization…

New and Evolving Clinical Trials: Embolotherapy

Dosing Radioembolization for HCC: Why Dose Calculation Is the Most I…

LEGACY: A Multicenter Study Confirming TheraSphere™ as a Neoadjuvant…

Liver Directed Therapy in 2021: What Are the Advances in Transarteri…

TheraSphere™ Y-90 Glass Microspheres: The DOSISPHERE-01 Trial

Liver-Directed Therapy for mCRC: What Is the Goal, When to Use and H…

Stage C HCC Clinical Data Review: Resin Radioembolization and Kinase…

TheraSphere™ Y-90 Glass Microspheres: The LEGACY Study

2L Yttrium-90 Radioembolization With Chemo for CRC Liver Metastases

Y90 Radiation Segmentectomy

Embolization Optimization with Proximal Protection: Principles and P…

Practical Approach to Y90 Dosimetry: Using the DAVYR App

Principles of Y90 Dosimetry

Liver Case Review: 9.5 cm Liver Mass- HCC

Top Three Clinical Studies in Y90

Macroaggregated Albumin (MAA) Prior to Planned SIRT Y90 Segmentectomy